Ataluren: A Novel Targeted Therapeutic Approach for the Treatment of Cystic Fibrosis
Journal Title: Journal of Biomedical and Pharmaceutical Research - Year 2013, Vol 2, Issue 2
Abstract
A lethal autosomal recessive genetic disease, cystic fibrosis (CF) is most common in Caucasians and the prevalence varies with the ethnic origin of the population. Patients with CF lack adequate levels of the CF transmembrane conductance receptor (CFTR) protein, a chloride channel necessary for normal function of the lung, pancreas, liver and other organs. Nonsense (premature stop codon) mutations in mRNA for the CFTR cause CF in approximately 10% of patients. Ataluren, a protein restoration therapy, is designed to promote the translational read-through of premature stop codons that helps to overcome the nonsense mutation and enable the production of a full-length, functional CFTR protein. Insertion of a near cognate amino acid at a premature stop codon allows the protein translation to continue until one of the several stop codons normally present at the ends of mRNA transcript is reached and properly utilized. It is a “corrector” drug specific for type I mutation defects. Ataluren is a novel, orally bioavailable drug that addresses the molecular basis of the disease. Phase III Clinical trials have shown it to be efficacious and well tolerated. It represents a breakthrough in the pharmacological advances for a rare genetic disease.
Authors and Affiliations
Suruchi Aditya*| Asstt. Prof, Department of Pharmacology, Dr. Harvansh Singh Judge Institute of Dental Sciences, Panjab University, Chandigarh, India, Surya Kant Mathur| Professor, Department of Pediatrics, MM Institute of Medical Sciences, Mullana, Ambala, India
Keywords
Related Articles
- EP ID EP1649
- DOI -
- Views 414
- Downloads 24
PLATELET COUNT, PLATELET INDICES, ERYTHROCYTE SEDIMENTATION RATE AND C-REACTIVE PROTEIN IN PULMONARY TUBERCULOSIS PATIENTS IN ABU-ANJA HOSPITAL
Background: Tuberculosis (TB) is a major public health problem in Sudan. The pulmonary type is the most important form of tuberculosis, continues to be one of the most wide spread infectious diseases. The differential di...
PHARMACEUTICAL EVALUATION OF FOUR BRANDS OF ATENOLOL TABLETS AVAILABLE IN OMAN
Atenolol is a widely used drug for treating heart conditions available worldwide under various trade names by several generic pharmaceutical manufacturers. Atenolol is a selective β1 receptor antagonist, a drug belongin...
FORMULATION AND EVALUATION OF MATRIX TYPE TRANSDERMAL PATCHES OF ATORVASTATIN CALCIUM
In present work was designed to develop suitable transdermal matrix type of Atorvastatin calcium, using Hydroxy propyl methyl cellulose (HPMC) and ethyl cellulose (EC) with PEG 400, n-DB (as plasticizers) and propylene...
PERINATAL OUTCOMES ASSOCIATED WITH MECONIUM STAINED NON VIGOROIUS BABIES IN A TERTIARY CENTRE OF UTTARAKHAND (INDIA)
We examined the perinatal outcomes in singleton pregnancies associated with meconium-stained amniotic fluid (MSAF) in non vigorous neonates.The study was performed during one year (2012-2013) in new borns admitted at o...
PREPARATION AND ASSESSMENT OF AMORPHOUS SOLID DISPERSIONS USING VARIOUS METHODOLOGIES
Amorphous products and particularly amorphous solid dispersions are currently one of the most upcoming and widely used areas in the pharmaceutical field. This approach offers huge potential and advantageous features rega...